Sergey Klykov has been appointed CEO of Pharm-Center JSC (Marathon Group), managing company of Sintez Kurgan Joint-Stock Company of Medicinal Products and Devices, and of Biokom CJSC.
"Our new CEO's top priority will be to expand production and introduce new medical products to the market, said Sergey Zakharov, chairman of the Marathon Group. "Sergey has extensive experience in successfully managing production assets. I believe his experience will be key in allowing Sintez and Biokom to reach new heights. We are glad to have Sergey on board and wish him great success. Sintez is one of the largest pharmaceutical companies in Russia. We are faced with interesting and ambitious tasks in terms of unlocking its potential, such as introducing new products to the market, implementing a long-term development strategy throughout all product segments, and expanding our sales channels", said Sergey Klykov.
Sergey Klykov graduated from the Kuban State Technological University with a degree in Economics and Agricultural Sector Management; he successfully defended his PhD thesis in 2005. During his PhD studies, Klykov also served as CEO of OAO Krasnodar Cooking Oil and Fat Plant (up until 2006). Under Klykov's leadership, the plant was named the leading regional enterprise in its industrial sector. Up until 2014, Klykov headed the Gulkevichsky Starch Plant LLC, where his team achieved an impressive increase in market share and capitalization. From 2014 to 2018, Klykov sreved as CEO of Unitile Group, which includes 18 subdivisions throughout Russia, and manages such enterprises as Shakhty Ceramics, Voronezh Ceramics, Markinsky Brick Plant, Vladimir High-Melting Clay Quarry, and Parallel Trading House. In two years, Klykov's management led to significant financial growth, and brought about a number of new products and formats to the market, especially to the premium segment.